世界のベッカー型筋ジストロフィー治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03028)
◆英語タイトル:Global Becker Muscular Dystrophy Drug Market Insights and Forecast to 2026
◆商品コード:QYR20NV03028
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはベッカー型筋ジストロフィー治療薬の世界市場について調査・分析した資料です。種類別(ジビノスタット、アタルレン、エピカテキン、ARM-210、その他)の市場規模、用途別(病院、診療所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ベッカー型筋ジストロフィー治療薬の競争状況、市場シェア
・世界のベッカー型筋ジストロフィー治療薬市場:種類別市場規模 2015年-2020年(ジビノスタット、アタルレン、エピカテキン、ARM-210、その他)
・世界のベッカー型筋ジストロフィー治療薬市場:種類別市場規模予測 2021年-2026年(ジビノスタット、アタルレン、エピカテキン、ARM-210、その他)
・世界のベッカー型筋ジストロフィー治療薬市場:用途別市場規模 2015年-2020年(病院、診療所、その他)
・世界のベッカー型筋ジストロフィー治療薬市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他)
・北米のベッカー型筋ジストロフィー治療薬市場分析:米国、カナダ
・ヨーロッパのベッカー型筋ジストロフィー治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのベッカー型筋ジストロフィー治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のベッカー型筋ジストロフィー治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのベッカー型筋ジストロフィー治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Italfarmaco SpA、Milo Biotechnology LLC、PTC Therapeutics Inc、ReveraGen BioPharma Inc、Sarepta Therapeutics Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Becker Muscular Dystrophy Drug Market
The global Becker Muscular Dystrophy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Becker Muscular Dystrophy Drug Scope and Market Size
Becker Muscular Dystrophy Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Becker Muscular Dystrophy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Becker Muscular Dystrophy Drug market is segmented into
Givinostat
Ataluren
Epicatechin
ARM-210
Others

Segment by Application, the Becker Muscular Dystrophy Drug market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Becker Muscular Dystrophy Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Becker Muscular Dystrophy Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Becker Muscular Dystrophy Drug Market Share Analysis
Becker Muscular Dystrophy Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Becker Muscular Dystrophy Drug business, the date to enter into the Becker Muscular Dystrophy Drug market, Becker Muscular Dystrophy Drug product introduction, recent developments, etc.

The major vendors covered:
Italfarmaco SpA
Milo Biotechnology LLC
PTC Therapeutics Inc
ReveraGen BioPharma Inc
Sarepta Therapeutics Inc

【レポートの目次】

1 Study Coverage
1.1 Becker Muscular Dystrophy Drug Product Introduction
1.2 Market Segments
1.3 Key Becker Muscular Dystrophy Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Becker Muscular Dystrophy Drug Market Size Growth Rate by Type
1.4.2 Givinostat
1.4.3 Ataluren
1.4.4 Epicatechin
1.4.5 ARM-210
1.4.6 Others
1.5 Market by Application
1.5.1 Global Becker Muscular Dystrophy Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Becker Muscular Dystrophy Drug Market Size, Estimates and Forecasts
2.1.1 Global Becker Muscular Dystrophy Drug Revenue 2015-2026
2.1.2 Global Becker Muscular Dystrophy Drug Sales 2015-2026
2.2 Global Becker Muscular Dystrophy Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Becker Muscular Dystrophy Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Becker Muscular Dystrophy Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Becker Muscular Dystrophy Drug Competitor Landscape by Players
3.1 Becker Muscular Dystrophy Drug Sales by Manufacturers
3.1.1 Becker Muscular Dystrophy Drug Sales by Manufacturers (2015-2020)
3.1.2 Becker Muscular Dystrophy Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Becker Muscular Dystrophy Drug Revenue by Manufacturers
3.2.1 Becker Muscular Dystrophy Drug Revenue by Manufacturers (2015-2020)
3.2.2 Becker Muscular Dystrophy Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Becker Muscular Dystrophy Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Becker Muscular Dystrophy Drug Revenue in 2019
3.2.5 Global Becker Muscular Dystrophy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Becker Muscular Dystrophy Drug Price by Manufacturers
3.4 Becker Muscular Dystrophy Drug Manufacturing Base Distribution, Product Types
3.4.1 Becker Muscular Dystrophy Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Becker Muscular Dystrophy Drug Product Type
3.4.3 Date of International Manufacturers Enter into Becker Muscular Dystrophy Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Becker Muscular Dystrophy Drug Market Size by Type (2015-2020)
4.1.1 Global Becker Muscular Dystrophy Drug Sales by Type (2015-2020)
4.1.2 Global Becker Muscular Dystrophy Drug Revenue by Type (2015-2020)
4.1.3 Becker Muscular Dystrophy Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Becker Muscular Dystrophy Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Becker Muscular Dystrophy Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Becker Muscular Dystrophy Drug Revenue Forecast by Type (2021-2026)
4.2.3 Becker Muscular Dystrophy Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Becker Muscular Dystrophy Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Becker Muscular Dystrophy Drug Market Size by Application (2015-2020)
5.1.1 Global Becker Muscular Dystrophy Drug Sales by Application (2015-2020)
5.1.2 Global Becker Muscular Dystrophy Drug Revenue by Application (2015-2020)
5.1.3 Becker Muscular Dystrophy Drug Price by Application (2015-2020)
5.2 Becker Muscular Dystrophy Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Becker Muscular Dystrophy Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Becker Muscular Dystrophy Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Becker Muscular Dystrophy Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Becker Muscular Dystrophy Drug by Country
6.1.1 North America Becker Muscular Dystrophy Drug Sales by Country
6.1.2 North America Becker Muscular Dystrophy Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Becker Muscular Dystrophy Drug Market Facts & Figures by Type
6.3 North America Becker Muscular Dystrophy Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Becker Muscular Dystrophy Drug by Country
7.1.1 Europe Becker Muscular Dystrophy Drug Sales by Country
7.1.2 Europe Becker Muscular Dystrophy Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Becker Muscular Dystrophy Drug Market Facts & Figures by Type
7.3 Europe Becker Muscular Dystrophy Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Becker Muscular Dystrophy Drug by Region
8.1.1 Asia Pacific Becker Muscular Dystrophy Drug Sales by Region
8.1.2 Asia Pacific Becker Muscular Dystrophy Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Becker Muscular Dystrophy Drug Market Facts & Figures by Type
8.3 Asia Pacific Becker Muscular Dystrophy Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Becker Muscular Dystrophy Drug by Country
9.1.1 Latin America Becker Muscular Dystrophy Drug Sales by Country
9.1.2 Latin America Becker Muscular Dystrophy Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Becker Muscular Dystrophy Drug Market Facts & Figures by Type
9.3 Central & South America Becker Muscular Dystrophy Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Becker Muscular Dystrophy Drug by Country
10.1.1 Middle East and Africa Becker Muscular Dystrophy Drug Sales by Country
10.1.2 Middle East and Africa Becker Muscular Dystrophy Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Becker Muscular Dystrophy Drug Market Facts & Figures by Type
10.3 Middle East and Africa Becker Muscular Dystrophy Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Italfarmaco SpA
11.1.1 Italfarmaco SpA Corporation Information
11.1.2 Italfarmaco SpA Description and Business Overview
11.1.3 Italfarmaco SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Italfarmaco SpA Becker Muscular Dystrophy Drug Products Offered
11.1.5 Italfarmaco SpA Related Developments
11.2 Milo Biotechnology LLC
11.2.1 Milo Biotechnology LLC Corporation Information
11.2.2 Milo Biotechnology LLC Description and Business Overview
11.2.3 Milo Biotechnology LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Products Offered
11.2.5 Milo Biotechnology LLC Related Developments
11.3 PTC Therapeutics Inc
11.3.1 PTC Therapeutics Inc Corporation Information
11.3.2 PTC Therapeutics Inc Description and Business Overview
11.3.3 PTC Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Products Offered
11.3.5 PTC Therapeutics Inc Related Developments
11.4 ReveraGen BioPharma Inc
11.4.1 ReveraGen BioPharma Inc Corporation Information
11.4.2 ReveraGen BioPharma Inc Description and Business Overview
11.4.3 ReveraGen BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Products Offered
11.4.5 ReveraGen BioPharma Inc Related Developments
11.5 Sarepta Therapeutics Inc
11.5.1 Sarepta Therapeutics Inc Corporation Information
11.5.2 Sarepta Therapeutics Inc Description and Business Overview
11.5.3 Sarepta Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Products Offered
11.5.5 Sarepta Therapeutics Inc Related Developments
11.1 Italfarmaco SpA
11.1.1 Italfarmaco SpA Corporation Information
11.1.2 Italfarmaco SpA Description and Business Overview
11.1.3 Italfarmaco SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Italfarmaco SpA Becker Muscular Dystrophy Drug Products Offered
11.1.5 Italfarmaco SpA Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Becker Muscular Dystrophy Drug Market Estimates and Projections by Region
12.1.1 Global Becker Muscular Dystrophy Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Becker Muscular Dystrophy Drug Revenue Forecast by Regions 2021-2026
12.2 North America Becker Muscular Dystrophy Drug Market Size Forecast (2021-2026)
12.2.1 North America: Becker Muscular Dystrophy Drug Sales Forecast (2021-2026)
12.2.2 North America: Becker Muscular Dystrophy Drug Revenue Forecast (2021-2026)
12.2.3 North America: Becker Muscular Dystrophy Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Becker Muscular Dystrophy Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Becker Muscular Dystrophy Drug Sales Forecast (2021-2026)
12.3.2 Europe: Becker Muscular Dystrophy Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Becker Muscular Dystrophy Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Becker Muscular Dystrophy Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Becker Muscular Dystrophy Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Becker Muscular Dystrophy Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Becker Muscular Dystrophy Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Becker Muscular Dystrophy Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Becker Muscular Dystrophy Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Becker Muscular Dystrophy Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Becker Muscular Dystrophy Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Becker Muscular Dystrophy Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Becker Muscular Dystrophy Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Becker Muscular Dystrophy Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Becker Muscular Dystrophy Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Becker Muscular Dystrophy Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Becker Muscular Dystrophy Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Italfarmaco SpA、Milo Biotechnology LLC、PTC Therapeutics Inc、ReveraGen BioPharma Inc、Sarepta Therapeutics Inc

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のベッカー型筋ジストロフィー治療薬市場2026:インサイト・予測(Global Becker Muscular Dystrophy Drug Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。